BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 8036006)

  • 1. Potent SHC tyrosine phosphorylation by epidermal growth factor at low receptor density or in the absence of receptor autophosphorylation sites.
    Soler C; Alvarez CV; Beguinot L; Carpenter G
    Oncogene; 1994 Aug; 9(8):2207-15. PubMed ID: 8036006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine phosphorylation of Shc proteins and formation of Shc/Grb2 complex correlate to the transformation of NIH3T3 cells mediated by the point-mutation activated neu.
    Xie Y; Li K; Hung MC
    Oncogene; 1995 Jun; 10(12):2409-13. PubMed ID: 7784091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new function for phospholipase C-gamma1: coupling to the adaptor protein GRB2.
    Pei Z; Maloney JA; Yang L; Williamson JR
    Arch Biochem Biophys; 1997 Sep; 345(1):103-10. PubMed ID: 9281317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SH2 domain of Shc suppresses EGF-induced mitogenesis in a dominant negative manner.
    Gotoh N; Muroya K; Hattori S; Nakamura S; Chida K; Shibuya M
    Oncogene; 1995 Dec; 11(12):2525-33. PubMed ID: 8545109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Shc: a neural-specific adapter molecule that mediates signaling from neurotrophin/Trk to Ras/MAPK pathway.
    Nakamura T; Sanokawa R; Sasaki Y; Ayusawa D; Oishi M; Mori N
    Oncogene; 1996 Sep; 13(6):1111-21. PubMed ID: 8808684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Shc in the activation of Ras in response to epidermal growth factor and nerve growth factor.
    Basu T; Warne PH; Downward J
    Oncogene; 1994 Dec; 9(12):3483-91. PubMed ID: 7970708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor activates phospholipase C in rat hepatocytes via a different mechanism from that in A431 or rat1hER cells.
    Liang M; Garrison JC
    Mol Pharmacol; 1992 Nov; 42(5):743-52. PubMed ID: 1435749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell density-dependent regulation of PLC gamma 1 tyrosine phosphorylation and catalytic activity in an intestinal cell line (IEC-6).
    Polk DB; McCollum GW; Carpenter G
    J Cell Physiol; 1995 Mar; 162(3):427-33. PubMed ID: 7532179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor increases protein and messenger RNA expression levels of Ras GTPase activating protein.
    Soler C; Felipe A; Carpenter G
    Cell Growth Differ; 1994 May; 5(5):519-26. PubMed ID: 8049158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of tyrosine kinases by alpha1A-adrenergic and growth factor receptors in transfected PC12 cells.
    Zhong H; Minneman KP
    Biochem J; 1999 Dec; 344 Pt 3(Pt 3):889-94. PubMed ID: 10585878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras.
    Gale NW; Kaplan S; Lowenstein EJ; Schlessinger J; Bar-Sagi D
    Nature; 1993 May; 363(6424):88-92. PubMed ID: 8386805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAP kinase phosphorylation of mSos1 promotes dissociation of mSos1-Shc and mSos1-EGF receptor complexes.
    Rozakis-Adcock M; van der Geer P; Mbamalu G; Pawson T
    Oncogene; 1995 Oct; 11(7):1417-26. PubMed ID: 7478566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Grb2 negatively regulates epidermal growth factor-induced phospholipase C-gamma1 activity through the direct interaction with tyrosine-phosphorylated phospholipase C-gamma1.
    Choi JH; Hong WP; Yun S; Kim HS; Lee JR; Park JB; Bae YS; Ryu SH; Suh PG
    Cell Signal; 2005 Oct; 17(10):1289-99. PubMed ID: 16038803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophosphorylation mutants of the EGF-receptor signal through auxiliary mechanisms involving SH2 domain proteins.
    Li N; Schlessinger J; Margolis B
    Oncogene; 1994 Dec; 9(12):3457-65. PubMed ID: 7970705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling.
    Zhang T; Ma J; Cao X
    Biochem J; 2003 Dec; 376(Pt 2):457-64. PubMed ID: 14498832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical receptor-mediated signal transduction events in the EGF-dependent growth-inhibited cell line, MDA-468.
    Church JG; Richardson VJ; Lockwood AG
    J Cell Physiol; 1992 Nov; 153(2):373-80. PubMed ID: 1331123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of hepatocyte epidermal growth factor receptor mediated activation of mitogen-activated protein kinase signaling pathways in response to growth inhibition by a novel K vitamin.
    Wang Z; Wang M; Carr BI
    J Cell Physiol; 2000 Jun; 183(3):338-46. PubMed ID: 10797308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine phosphorylation of ras GTPase-activating protein does not require association with the epidermal growth factor receptor.
    Soler C; Beguinot L; Sorkin A; Carpenter G
    J Biol Chem; 1993 Oct; 268(29):22010-9. PubMed ID: 8408058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation.
    Lipson KE; Pang L; Huber LJ; Chen H; Tsai JM; Hirth P; Gazit A; Levitzki A; McMahon G
    J Pharmacol Exp Ther; 1998 May; 285(2):844-52. PubMed ID: 9580635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor-receptor mutant lacking the autophosphorylation sites induces phosphorylation of Shc protein and Shc-Grb2/ASH association and retains mitogenic activity.
    Gotoh N; Tojo A; Muroya K; Hashimoto Y; Hattori S; Nakamura S; Takenawa T; Yazaki Y; Shibuya M
    Proc Natl Acad Sci U S A; 1994 Jan; 91(1):167-71. PubMed ID: 7506413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.